100 Active Studies

Advanced Solid Tumors Clinical Trials Near You

Find 100 actively recruiting advanced solid tumors research studies near you. Connect with study sites, check eligibility, and explore new treatment options.

100Active Trials
169+Locations
132,750Participants Needed

Recruiting Studies

Advanced Search

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Top Cities for Advanced Solid Tumors Clinical Trials

Advanced Solid Tumors clinical trials are recruiting across 169 cities. Here are the cities with the most active studies:

Advanced Solid Tumors Trial Phases

PHASE1(74 studies)
PHASE2(45 studies)
NA(4 studies)
PHASE3(2 studies)

72 research organizations are sponsoring advanced solid tumors trials.

About Advanced Solid Tumors

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

Clinical trials are advancing new treatments for advanced solid tumors. Currently, 100 studies are recruiting a combined 132,750 participants across the United States. Research is being conducted by 72 organizations including Wake Forest University Health Sciences, Mayo Clinic, Indiana University and 69 others.

2026 Advanced Solid Tumors Research Landscape

As of July 2026, the advanced solid tumors clinical trial landscape includes 100 actively recruiting studies across 169 cities in the United States. These studies are collectively seeking 132,750 participants, with an average enrollment target of 1,328 per study.

The research spans multiple phases of development: 74 studies are in PHASE1, 45 studies are in PHASE2, 4 studies are in NA, 2 studies are in PHASE3. The presence of Phase 3 trials indicates that some advanced solid tumors treatments are in late-stage testing and may be approaching regulatory review.

Research is being led by 72 different organizations, including Wake Forest University Health Sciences, Mayo Clinic, Indiana University, National Cancer Institute (NCI), University of Texas Southwestern Medical Center, and 67 others. The large number of sponsors reflects significant research interest and investment in advanced solid tumors treatment advancement.

Geographically, advanced solid tumors trials are most concentrated in Boston, Massachusetts (36 trials); Los Angeles, California (33 trials); New York, New York (33 trials); Houston, Texas (26 trials); Nashville, Tennessee (20 trials) and 7 other cities.

Featured Advanced Solid Tumors Studies

Highlighted recruiting studies for advanced solid tumors, selected by enrollment size and research scope.

RecruitingNCT00900471

Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

RATIONALE: Collecting and storing samples of tissue or blood from patients with cancer for study in the laboratory may help the study of cancer in the future PURPOSE: This research study is collecting and storing blood and tissue samples from patients with suspected solid tumors.

Sponsor: Wake Forest University Health Sciences· 20,000 participants· 1 location (Winston)
View full study details →
RecruitingNCT02457962

Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.

Sponsor: Mayo Clinic· 15,000 participants· 1 location (Rochester)
View full study details →
RecruitingNCT06081517

Evaluating Disparities in Precision Oncology

This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.

Sponsor: Indiana University· 10,600 participants· 1 location (Indianapolis)
View full study details →

Frequently Asked Questions About Advanced Solid Tumors Clinical Trials

Are there advanced solid tumors clinical trials near me?

Yes, there are 100 advanced solid tumors clinical trials currently recruiting across 169+ cities in the United States, including Boston, Massachusetts; Los Angeles, California; New York, New York. Browse the studies above to find one at a location convenient for you.

How do I join a advanced solid tumors clinical trial?

To join a advanced solid tumors clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.

Are advanced solid tumors clinical trials free?

Yes, participation in advanced solid tumors clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.

What types of advanced solid tumors treatments are being studied?

Current advanced solid tumors clinical trials are testing a range of approaches across PHASE1 (74 studies), PHASE2 (45 studies), NA (4 studies), PHASE3 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 72 research organizations.

Is it safe to participate in advanced solid tumors clinical trials?

Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.

Data updated July 16, 2026 from ClinicalTrials.gov

About This Data

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.

Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.

Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov